SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-18-015062
Filing Date
2018-11-01
Accepted
2018-11-01 17:03:46
Documents
2
Period of Report
2018-10-29

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 1589
2 scholefieldpoa.txt EX-24 2859
  Complete submission text file 0001225208-18-015062.txt   5927
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Scholefield James H (Reporting) CIK: 0001720922 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 181154653